Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
Lin Chen,1,* Xiujuan Zhang,2,* Li Zhang,3 Dongmei Zheng2 1Department of Breast and Thyroid Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People’s Republic of China; 2Department of Endocrinology, Shandong Provincial Hospital Affili...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-10-01
|
| Series: | Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/effect-of-saxagliptin-a-dipeptidyl-peptidase-4-inhibitor-on-non-alcoho-peer-reviewed-article-DMSO |